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Background: The value of fractional excretion (FE) of electrolytes to characterize and prognosti-
cate acute kidney injury (AKI) is poorly documented in dogs.
Objectives: To evaluate the diagnostic and prognostic roles of FE of electrolytes in dogs with AKI.
Animals: Dogs (n5135) with AKI treated with standard care (February 2014-December 2016).
Methods: Prospective study. Clinical and laboratory variables including FE of electrolytes, were
measured upon admission. Dogs were graded according to the AKI-IRIS guidelines and grouped
according to AKI features (volume-responsive, VR-AKI; intrinsic, I-AKI) and outcome (survivors/
non-survivors). Group comparison and regression analyses with hazard ratios (HR) evaluation for I-
AKI and mortality were performed. P< .05 was considered significant.
Results: Fifty-two of 135 (39%) dogs had VR-AKI, 69/135 (51%) I-AKI and 14/135 (10%) were
unclassified. I-AKI dogs had significantly higher FE of electrolytes, for example, FE of sodium
(FENa, %) 2.39 (range 0.04-75.81) than VR-AKI ones 0.24 (range 0.01-2.21; P< .001). Overall, case
fatality was 41% (55/135). Increased FE of electrolytes were detected in nonsurvivors, for exam-
ple, FENa 1.60 (range 0.03-75.81) compared with survivors 0.60 (range 0.01-50.45; P5 .004).
Several risk factors for death were identified, including AKI-IRIS grade (HR51.39, P5 .002), FE of
electrolytes, for example, FENa (HR51.03, P< .001), and urinary output (HR55.06, P< .001).
Conclusions and Clinical Importance: Fractional excretion of electrolytes performed well in the
early differentiation between VR-AKI and I-AKI, were related to outcome, and could be useful
tools to manage AKI dogs in clinical practice.
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Abbreviations: AKI, acute kidney injury; AUC, area under the curve; BE, base excess; CI, confidence interval; CKD, chronic kidney disease; CRP, C-reactive
protein; FE, fractional excretion; FECa, fractional excretion of calcium; FECl, fractional excretion of chloride; FEK, fractional excretion of potassium; FEMg,
fractional excretion of magnesium; FENa, fractional excretion of sodium; FEP, fractional excretion of phosphorus; FEurea, fractional excretion of urea; GFR,
glomerular filtration rate; HR, hazard ratio; iCa, ionized calcium; ICU, intensive care unit; NA, not applicable; ROC, receiver operator characteristic; SBP, systolic
blood pressure; sCr, serum creatinine; SD, standard deviation; UAC, urine albumin to creatinine ratio; uCr, urine creatinine; uCr/sCr, urine creatinine to serum
creatinine ratio; uGlucose/uCr, urine glucose to creatinine ratio; UO, urine output; UPC, urine protein to creatinine ratio; USG, urine specific gravity; uUA/uCr,
urine uric acid to creatinine ratio; VTH, veterinary teaching hospital.
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1 | INTRODUCTION
Acute kidney injury (AKI) is a broad clinical syndrome characterized by
sudden renal damage or dysfunction, frequently associated with a
reduction in urine output (UO).1,2 The diagnosis of AKI still relies on
clinical findings and relative or absolute changes in serum creatinine
(sCr) and UO in humans.1 Acute kidney injury is gaining attention in
small animal medicine, but universally accepted diagnostic criteria are
lacking.3,4 Recently, an AKI grading system for dogs was proposed by
Cowgill,5 accepted by the IRIS group (http://www.iris-kidney.com/pdf/
grading-of-acute-kidney-injury.pdf), and applied in clinical settings.6–9
Diagnostic criteria and five AKI grades based on medical data, sCr con-
centrations, and UO are suggested. Definitions for non-azotemic and
volume-responsive AKI are proposed in the guidelines. These criteria
are still rarely used for AKI diagnosis in veterinary clinical practice.
The terms “volume-responsive” and “intrinsic” AKI have been pro-
posed in human medicine to ameliorate the classification of “prerenal”
and “renal” kidney injury.10,11 While the concept of intrinsic AKI refers
to structural damage to the renal parenchyma, volume-responsive AKI
is characterized by a transient reduction of renal function, which can
be reversed after short-term fluid administration.10,11 Despite its
potential reversibility and superior short-term prognosis, when com-
pared with the intrinsic form, volume-responsive AKI is an independent
risk factor for mortality in humans.12,13 Moreover, clinicopathological
or even pathological findings of renal damage have been detected in
the latter state.11,12,14,15 Studies designed to compare these conditions
are lacking in dogs.
Serum and urine chemistry, including the evaluation of the frac-
tional excretion (FE) of electrolytes, are used in the assessment of
human AKI aiming to differentiate between functional and structural
kidney injury and give prognostic information.10 Specifically, volume-
responsive AKI is characterized by low (<1%) FE of sodium (FENa),
increased (>35%) FE of urea (FEurea), and increased urine creatinine
(uCr) to sCr ratio (uCr/sCr; >40).10 The validity of this diagnostic para-
digm in clinical practice, however, has been questioned due to the
impact of different confounders (diuretic or vasopressor administration,
fluid therapy, or specific AKI etiologies).16–18
Fractional excretion of electrolytes have been recently re-
evaluated in dogs with AKI as readily available and cost-effective
markers of tubular damage and kidney function.2,7 Fractional excretion
of sodium was an early and accurate predictor of AKI in a population of
dogs with naturally occurring heatstroke despite fluid resuscitation.7
Additionally, a recent investigation evaluated the prognostic value of
sequential changes of glomerular filtration rate (GFR), UO, and renal
solute excretion in 10 dogs with naturally occurring AKI.2 Increased
GFR and UO, and decreased FENa during hospitalization were associ-
ated with renal recovery and predicted survival in this population.2
The main objective of the current study was to evaluate the per-
formance of clinical and clinicopathological variables, focusing on the
FE of electrolytes and urea, in early differentiation between volume-
responsive and intrinsic AKI in a population of dogs with naturally
occurring AKI and to investigate their potential for outcome prediction
at the time of hospital admission. In addition, the prognostic power of
an AKI grading system for dogs (http://www.iris-kidney.com/pdf/grad-
ing-of-acute-kidney-injury.pdf)5 was assessed. Our hypothesis was that
the FE of electrolytes and urea could predict the occurrence of
volume-responsive or intrinsic AKI in dogs early, and that the AKI grade
and urine chemistry were of prognostic value during AKI.
2 | MATERIALS AND METHODS
2.1 | Study design
This was a prospective, observational case-control study with intensive
care unit (ICU) follow-up performed at a Veterinary Teaching Hospital
(VTH), between February 2014 and December 2016.
2.2 | Animals
Dogs with naturally occurring AKI hospitalized in the ICU of our VTH
were considered for the study. Inclusion criteria were acute onset of
clinical signs (<7 days) and signalment; history; and clinical, clinicopa-
thological, and imaging findings suggesting AKI.19 In particular, sCr
>1.6 mg/dL (azotemic AKI) or a progressive non-azotemic 0.3 mg/dL
increase in sCr from baseline within 48 hours, persistent oliguria/anuria
(UO <1 mL kg21 h21) over 6 hours, or both criteria were required, as
previously reported (http://www.iris-kidney.com/pdf/grading-of-acute-
kidney-injury.pdf).5,19 Dogs with historical, clinical, laboratory, and
imaging findings consistent with chronic kidney disease (CKD), AKI on
CKD, postrenal AKI (eg, uroabdomen, urinary tract obstruction), and
dogs who received treatments known to increase urinary electrolyte
excretion (eg, diuretics, hypertonic saline) before the admission to the
ICU were excluded from the study. Additionally, dogs that were eutha-
nized for reasons other than ethical ones were also excluded.
2.3 | Grouping
Dogs were graded (I-V) according to the IRIS grading system for AKI at
the time of AKI diagnosis and through the overall study period.
Volume-responsive or intrinsic AKI were classified according to the
IRIS guidelines for AKI (http://www.iris-kidney.com/pdf/grading-of-
acute-kidney-injury.pdf).5 Specifically, volume-responsive AKI was
defined as an increase in urine production above 1 mL kg21 h21 over 6
hours of adequate fluid therapy, or a decrease in sCr concentrations to
baseline over 48 hours. On the contrary, intrinsic AKI was defined as
persistent azotemia for longer than 48 hours, inappropriate oligo/anu-
ria despite appropriate fluid therapy once any volume deficit had been
restored and euvolemia achieved, or both. Furthermore, dogs were
classified according to their outcome as survivors if discharged alive
and as nonsurvivors if they died despite medical treatment or were
humanely euthanized for ethical reasons. For all dogs, the total number
of days spent in the ICU was recorded. In addition, 14-day survival and
1-month follow-up were recorded for survivors.
A group of dogs (n581) considered healthy according to history,
physical examination, and clinicopathological and imaging data were
included as controls.
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2.4 | Clinical and clinicopathological data
Complete clinical and laboratory data were collected and analyzed at the
time of AKI diagnosis; clinical monitoring was performed and recorded
during the overall duration of hospital stay. The Apple Fast score for ill-
ness severity was calculated.20 Daily recorded clinical data included body
weight, body temperature, heart rate, respiratory rate, noninvasive sys-
tolic blood pressure (SBP) measured using Doppler (Minidop ES-100VX
Hadeco Inc, Kawasaki, Japan) or an oscillometric device (petMAPTM
graphic, Ramsey Medical, Inc, Tampa, Florida) according to the ACVIM
guidelines,21 hydration/volume status, fluid input, and UO (mL). For the
purpose of the study, UO was measured at the time of hospital admission
to achieve AKI diagnosis. Only once fluid resuscitation had been per-
formed and fluid therapy instituted for at least 6 hours, UO was used to
classify AKI (intrinsic/volume-responsive) and then during the overall hos-
pital stay. Dogs received medical management and supportive care based
on the assessment made by the ICU team and the nephrologists. Treat-
ments were targeted to each dog individually, depending on the severity
of clinical signs, hydration/volume status, UO, presence of specific organ
dysfunction and electrolytes abnormalities, and presumptive or confirmed
etiology of AKI. Leptospirosis was considered a differential diagnosis in
dogs with known risk factors exposure and indicative clinical and labora-
tory findings, and diagnosed by means of a single microagglutination test
titer 1:800 for nonvaccinal serovars or by the evidence of a 4-fold
increase in the titer in paired serum samples (convalescent titer). Sepsis
was diagnosed in cases of systemic inflammatory response syndrome22
and evidence of a septic focus by means of cytology or microbiology. Dis-
continuation of fluid therapy and diuretic administration were performed
in cases of oligo/anuria attributed to intrinsic AKI, presence of fluid over-
load, or both conditions. Treatment of AKI was provided through conven-
tional medical therapy (n5134) and peritoneal dialysis (n51).
Blood specimens were collected by standard venipuncture using
blood vacuum collection systems; concurrent urine specimens were
obtained by means of cystocentesis, spontaneous voiding, or catheteri-
zation. Samples were collected and analyzed within 1 hour after inclu-
sion. The following analyses were performed: venous or arterial blood
gas analysis including pH, base excess (BE), anion gap, lactate, and ion-
ized calcium (iCa) concentration; CBC; and chemistry profile including
sCr, albumin, total proteins, glucose, alanine transaminase, aspartate
transaminase, alkaline phosphatase, total bilirubin, g-glutamyltransferase,
cholesterol, sodium, potassium, magnesium, chloride, total calcium, phos-
phorus, C-reactive protein (CRP), and uric acid. Urinalysis included urine
specific gravity (USG), dipstick examination, microscopic evaluation of
the urine sediment, uCr, urine protein to creatinine ratio (UPC), urine
albumin to creatinine ratio (UAC), urinary electrolytes, urea and uric acid
to creatinine ratio (uUA/uCr). Pigmented urine specimens were excluded
from UAC and UPC measurements. The study was approved by the local
Scientific Ethical Committee for Animal Testing.
2.5 | Laboratory methods
CBC was obtained using an automated hematology system (ADVIA
2120, Siemens Healthcare Diagnostics, Tarrytown NY). C-reactive
protein (CRP OSR6147, Olympus/Beckman Coulter, O’Callaghan’s
Mills, Ireland) and urinary albumin (MICROALBUMIN OSR6167, Olym-
pus/Beckman Coulter, O’Callaghan’s Mills, Ireland) were measured
using immunoturbidimetric assays previously validated in our labora-
tory for dogs.23 Blood gas analysis was determined by a blood gas ana-
lyzer (ABL 800 Flex, Radiometer Medical ApS, Brønshøj, Denmark).
Urine specific gravity was measured by a hand refractometer (American
Optical, Buffalo, New York). Urinary proteins and uCr were measured
using commercially available colorimetric methods (Urinary/CSF Pro-
tein, OSR6170, Olympus/Beckman Coulter, O’Callaghan’s Mills, Irleand;
Creatinine OSR6178, Olympus/Beckman Coulter, O’Callaghan’s Mills,
Ireland). Fractional excretion of electrolytes including FENa, FE of
potassium (FEK), FE of chloride (FECl), calcium (FECa), phosphate (FEP),
magnesium (FEMg), and FEurea were calculated according to the equa-
tion reported previously,2 as follows:
FEX5 uX sCr=uCr sX based on spot urine sampleð Þ
where uX and sX were the concentrations of a specific analyte in urine
and serum, respectively. Urinary uric acid concentrations were meas-
ured using a colorimetric method (URIC ACID OSR6098 Olympus/
Beckman Coulter, O’Callaghan’s Mills, Ireland) and expressed as the
uUA/uCr ratio. The uCr/sCr ratio was calculated. All analyses were per-
formed using an automated chemistry analyzer (OLYMPUS AU 400,
Olympus/Beckman Coulter, Brea, California).
2.6 | Statistical Analysis
Data were expressed by standard descriptive statistics and presented
as mean6 standard deviation (SD) or median and (range), based on
their distribution. Normality was assessed graphically and by using the
D’Agostino-Pearson test. The Mann-Whitney U test and Kruskall-
Wallis test with compensated post hoc analysis were used to evaluate
differences between groups (intrinsic AKI, volume-responsive AKI and
control dogs; survivors and nonsurvivors). Unclassified dogs in respect
to AKI categories (n514) were excluded from the comparison. Cate-
gorical variables were compared using the chi-squared test. Logistic
regression and Cox proportional regression analyses (using univariate
and multivariate models) were performed to evaluate risk factors for
the presence of intrinsic AKI and outcome (death/survival at discharge;
stepwise approach), respectively. Results were presented as hazard
ratios (HR) and 95% confidence intervals (CI). Overall model fit was
assessed by the percentage of outcome correctly classified by receiver
operator characteristic (ROC) curve analysis and by the chi-squared
test for the relationship between time and all the covariates in the
model. Receiver operator characteristic curves were used to find opti-
mal cut-off values with the maximal sum of sensitivity and specificity
for variables discriminating between volume-responsive AKI and
healthy controls, between volume-responsive and intrinsic AKI, and
between survivors and nonsurvivors. The area under the ROC curve
(AUC) was calculated. Results of all statistics were considered signifi-
cant if P< .05. Statistical analyses were performed using an online
available statistical software (MedCalc Statistical Software version
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13.3.1 [MedCalc Software bvba, Ostend, Belgium; http://www.med-
calc.org; 2014]).
3 | RESULTS
A total of 135 dogs with AKI were included in the study. Median age
was 7 years (0.3–16), and median body weight was 19.4 kg (1.3–69.6).
Sex distribution was as follows: 54/135 (40%) intact males, 13/135
(10%) castrated males, 39/135 (29%) intact females, and 29/135 (21%)
spayed females. Mixed-breed dogs were 49/135 (36%), while purebred
dogs were 86/135 (64%). Median length of hospitalization was 5 days
(1–20).
3.1 | Characterization of dogs with AKI
According to the IRIS grading of AKI, the following AKI grades of sever-
ity were documented in the study population: 32/135 dogs (24%) AKI
grade I, 39/135 (29%) AKI grade II, 25/135 (18%) AKI grade III, 27/135
(20%) AKI grade IV, and 12/135 (9%) AKI grade V.
Continuous UO monitoring was obtained by means of an indwell-
ing urinary catheter connected to a closed urinary drainage system
(n5100) or through voided urine collection and quantification (n525).
Urine specimens and UO monitoring were not available in 10/135
cases because of complete anuria. Oligo/anuria was present in 47/135
(35%) dogs at the time of inclusion in the study: 37/135 dogs had inap-
propriate oligo/anuria and were in the intrinsic-AKI group, 5/135 dogs
had appropriate oligo/anuria and were classified as volume-responsive
AKI based on sCr changes. Five additional dogs had oligo/anuria at the
initial stages of hospitalization, but early death precluded any further
classification in regard to UO. Attempts to convert oligo/anuria to pol-
yuria were made through diuretic therapy in 32/37 dogs with inappro-
priate oligo/anuria: in 10 dogs, UO response after furosemide
administration was noticed. In the remaining 22 dogs, mannitol, diltia-
zem, or both drugs were considered in the absence of contraindica-
tions, without any significant increase in urine production.
Fifty-two of 135 dogs (39%) were diagnosed as having volume-
responsive AKI, while intrinsic AKI was recognized in 69/135 (51%)
dogs. AKI classification was not performed in 14/135 (10%) cases
because of early death. Causes of AKI and comorbidities in the study
population are reported in Table 1.
Overall, 80/135 (59%) dogs were classified as survivors and 55/
135 (41%) as nonsurvivors. All survivors were also alive at 14 and 30
days of follow-up. Significantly higher frequencies of death were
detected in dogs with intrinsic compared with volume-responsive AKI
(52.2% versus 17.3%, P< .001), and in dogs with oligo/anuria, as previ-
ously defined, compared with nonoliguric ones (69.8% versus 23.9%,
P< .001). Frequency of death was significantly higher in dogs with
oligo/anuria than in dogs with intrinsic AKI dogs (P5 .007).
3.2 | Acute kidney injury group comparison
Results and main significant differences among dogs with volume-
responsive AKI, dogs with intrinsic AKI, and healthy controls are
reported in Table 2. Specifically, dogs diagnosed with intrinsic AKI had
significantly increased SBP, AKI grade, sCr, urea, magnesium, phospho-
rus, total bilirubin, anion gap, FE of electrolytes, and UPC and signifi-
cantly decreased blood pH, iCa, USG, uCr, and uCr/sCr compared with
dogs with volume-responsive AKI and control dogs (Table 2 and Sup-
porting Information Table S5). Dogs with volume-responsive AKI had
significantly higher lactate concentration and uUA/uCr than dogs with
intrinsic AKI and controls. No statistically significant difference was
detected for CRP and Apple Fast score between dogs with intrinsic
and volume-responsive AKI (Table 2 and Supporting Information Table
S5). Results of univariate and multivariate logistic regression analysis
for the risk of having intrinsic AKI at the time of AKI diagnosis are
reported in Figure 1. Acute kidney injury grade and BE were the only
variables retained in the multivariate model.
Nonsurvivors had significantly higher AKI grade, sCr, urea, potas-
sium, phosphorus, magnesium, total bilirubin, anion gap, FE of electro-
lytes, UPC, and Apple Fast score values and significantly lower
TABLE 1 Recognized causes and diseases associated with AKI in the study population
AKI etiologies/comorbidities Volume-responsive AKI (n5 52) Intrinsic AKI (n569) Unclassified AKI (n514)
Leptospirosis 26 1
Toxic
Nonsteroidal anti-inflammatory drugs 4
Ethylene glycol 4
Noninfectious inflammatory diseases 18 11 3
Neoplasia 2 3 1
Sepsis 21 6 3
Trauma 6 3 1
Diabetic ketoacidosis 3
Heatstroke 2 1 3
Gastric dilatation-volvulus 3 1
Undetermined etiology/miscellanea 7 2
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hemoglobin, iCa, BE, pH, and uCr/sCr values than survivors (Table 3
and Supporting Information Table S7). These findings were mainly con-
firmed when the comparison between survivors (n533) and nonsurvi-
vors (n536) was performed in dogs having intrinsic AKI (Supporting
Information Table S8). Several variables were associated with an
increased risk of death in the overall population of dogs with AKI. Base
excess, total bilirubin, and iCa were retained in the multivariate model
(Figure 2 and Supporting Information Table S9).
Results of ROC curve analyses evaluating the FE of electrolytes
and uCr/sCr for the discrimination between volume-responsive AKI
and healthy controls, volume-responsive and intrinsic AKI, and survi-
vors and nonsurvivors are reported in Table 4.
4 | DISCUSSION
Our study characterized clinical and clinicopathological features of AKI
occurring in a wide population of critically ill dogs. The prevalence rates
of intrinsic and volume-responsive AKI were similar in the study popu-
lation. Causes and diseases associated with AKI were various and
TABLE 2 Descriptive statistics and comparison among intrinsic AKI, volume-responsive AKI, and control dogs for clinical and clinicopathologi-
cal variables
Variable AKI (n5135)
Intrinsic AKI
(n569)
Volume-responsive
AKI (n5 52)
Controls
(n5 81) P value
Clinical variables and scores
AKI IRIS grading 2 (1–5) 4 (1–5)b 2 (1–4) NA <.001
UO (mL kg21 h21; over 12 h) 1.2 (0.0–7.0) 1.461.2 1.3 (0.6–7.0) NA .061
APPLE fast score 23.26 6.3a 22 (12–44)a 21.76 6.4a 11 (7–15) <.001
SBP (mm Hg) 154635a 1606 34a,b 148635a 128611 <.001
Serum chemistry (n5 135)
Creatinine (mg/dL) 2.41 (0.57-21.39)a 5.22 (1.41-21.39)a,b 1.796 1.69a 1.0760.15 <.001
Urea (mg/dL) 139 (16–785)a 233 (30–785)a,b 85 (16–441)a 3468 <.001
Urea/creatinine (mg/mg) 41.7 (16.6–139.7)a 40.5 (17.8–95.2)a 43.3 (18.5–137.8)a 32.868.9 <.001
Phosphate (mg/dL) 7.7 (0.8–42.2)a 11.4 (1.1–42.2)a,b 5.962.7a 3.760.6 <.001
Albumin (mg/dL) 2.756 0.69a 2.7860.64a 2.706 0.76a 3.2760.28 <.001
Chloride (mmol/L) 104 (59–123)a 1056 15a,b 109 (71–122)a 113 (107–119) <.001
Sodium (mmol/L)) 143 (116–163)a 142 (116–154)a,b 14466a 14663 <.001
Potassium (mmol/L) 4.2 (2.3–8.7)a 4.4 (2.3–8.7)b 4.060.6a 4.5 (3.8-5.3) <.001
Magnesium (mg/dL) 2.70 (1.11-6.10)a 3.08 (1.43-6.10)a,b 2.30 (1.11-5.60)a 2.0460.22 <.001
CRP (mg/dL) 8.08 (0.44–45.48)a 7.07 (0.44–45.48)a 8.83 (0.90-38.85)a 0.22 (0.01-0.5) <.001
Blood gas analysis (n5135)
pH 7.30 (6.90-7.50)a 7.30 (6.90-7.50) a 7.326 0.09 7.3560.03 .017
HCO–3 (mmol/L) 17.5 (6.6–40.0)
a 17.266.5a 18.4 (9.1–40.0)a 20.961.6 .002
BE (mmol/L) 27.1 (–28.0–43.0)a 28.66 7.6a 25.8 (–17.2–43.0)a 23.46 1.3 .001
Anion gap (mmol/L) 20.76 7.3a 23.067.8a,b 17.86 5.6a 6.8 (3.6–15.0) <.001
Ionized calcium (mmol/L) 1.16 (0.49-1.41)a 1.0360.24a,b 1.186 0.13a 1.29 (1.07-1.36) <.001
Lactate (mmol/L) 2.2 (0.3–20.0)a 1.7 (0.3–20.0)a,b 3.261.9a 0.960.3 <.001
Urinalysis (n5 125)
USG 1020 (1007–1074)a 1016 (1008–1050)a,b 1028 (1007–1074)a 10446 14 <.001
uCr (mg/dL) 92.0 (7.6–769.8)a 75.3 (7.6–422.5)a,b 130 (18–770)a 3166145 <.001
UPC (mg/mg) 1.62 (0.09–72.00)a 2.21 (0.09–72.00)a,b 1.00 (0.10-10.15)a 0.07 (0.04-0.28) <.001
UAC (mg/mg) 0.41 (0.00–55.71)a 0.44 (0.02–55.71)a 0.40 (0.00–5.11)a 0.00 (0.00-0.03) <.001
FENa (%) 0.94 (0.01–75.81)a 2.36 (0.04–75.81)a,b 0.24 (0.01–2.21) 0.20 (0.02-1.11) <.001
FECl (%) 0.89 (0.03–83.45)a 2.70 (0.06–83.45)a,b 0.22 (0.03-3.14)a 0.42 (0.04-1.71) <.001
FEK (%) 41.7 (1.6–399.7)a 74.9 (5.3–399.7)a,b 23.3 (1.6–74.1)a 9.4763.68 <.001
FECa (%) 1.04 (0.05–70.02)a 4.1 (0.1–70.0)a,b 0.3 (0.1–3.7)a 0.08 (0.02-0.82) <.001
FEMg (%) 5.6 (0.3–131.8)a 10.2 (0.9–80.9)a,b 2.9 (0.3–13.8)a 1.61 (0.04–6.30) <.001
FEP (%) 25.8 (0.4–233.5)a 38.4624.9a,b 17.96 13.4 13.24 (0.17–45.91) <.001
FEurea (%) 39.9 (2.5–533.8)a 45.0 (2.5–121.2)a 38.76 17a 57.91612.60 <.001
uUA/uCr (mg/mg) 0.07 (0.00–2.56)a 0.05 (0.01-0.81)b 0.14 (0.00–2.56) 0.05 (0.02-0.15) <.001
uGlucose/uCr (mg/mg) 0.21 (0.01–58.19)a 0.32 (0.01–58.19)a,b 0.09 (0.01-0.93)a 0.03 (0.01-0.11) <.001
uCr/sCr (mg/mg) 34 (1–546)a 14 (1–218)a,b 78 (10–546)a 285 (50–780) <.001
Data are reported as mean6 SD or median and (range) based on their distribution.
Abbreviations: AKI, acute kidney injury; BE, base excess; CRP, C-reactive protein; FECa, fractional excretion of calcium; FECl, fractional excretion of
chloride; FEK, fractional excretion of potassium; FEMg, fractional excretion of magnesium; FENa, fractional excretion of sodium; FEP, fractional excre-
tion of phosphate; FEurea, fractional excretion of urea; NA, not applicable; SBP, systolic blood pressure; UAC, urine albumin to creatinine ratio; uCr,
urine creatinine; uCr/sCr, urine creatinine to serum creatinine ratio; uGlucose/uCr, urine glucose to creatinine ratio; UO, urinary output; UPC, urine pro-
tein to creatinine ratio; USG, urinary specific gravity; uUA/uCr, urine uric acid to creatinine ratio.
aSignificantly different from control dogs.
bSignificantly different from dogs with volume-responsive AKI.
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mainly related to septic and noninfectious inflammatory conditions.
These results are in partial contrast with the available veterinary litera-
ture, as volume-responsive AKI seems to be poorly represented, and
AKI during sepsis or systemic inflammation is scarcely documented in
dogs.4,19,24–26 On the contrary, systemic inflammation and sepsis are
the most common conditions associated with AKI in humans.4,12 Our
findings might be due to a different case series composition and case
selection based on the novel and more sensitive diagnostic criteria for
AKI used.
Several clinical and clinicopathological variables could discriminate
between intrinsic and volume-responsive AKI at the time of diagnosis
in the study population. In particular, higher SBP, a more severe reduc-
tion of renal function, and a lower urinary concentrating ability associ-
ated with higher concentrations of urine proteins and greater
electrolytes losses, were significantly related to the presence of intrin-
sic AKI. These results suggest that the structural integrity of renal
tubules and parenchyma are more severely compromised during
intrinsic AKI, with subsequent uremic toxin accumulation and more
serious acid/base derangements.27
Fractional excretion of various electrolytes performed similarly and
well overall in the differentiation between intrinsic and volume-
responsive AKI, being potentially promising and easy to obtain at the
time of AKI diagnosis. Interestingly, the cut-off values of FENa and
uCr/sCr detected in the current study are in line with the ones recog-
nized and recommended in humans.10 Fractional excretion of urea was
not different between intrinsic and volume-responsive AKI and control
dogs, refuting our initial hypothesis. Species-specific differences due to
urea metabolism, renal handling, and dietary supply might potentially
account for the lack of its diagnostic significance, in contrast to the
data reported in humans,10,18 and warrant further investigations.
Significant increases in blood lactate concentration and uUA/uCr
were documented in dogs with volume-responsive AKI compared with
those with intrinsic AKI and healthy dogs. A more severe grade of tis-
sue hypoperfusion characterizing volume-responsive AKI might explain
FIGURE 1 Forest plot showing results of the univariate and multivariate logistic regression analyses for the prediction of intrinsic AKI in
the study population. Black rhombus represents HR reported as percentage of risk (HR%). The horizonal black line indicates the 95%
confidence interval values. Asterisk indicates variables retained in the multivariate model. The upper limit of 95% Confidence Interval for
AKI grade in the multivariate model was 17392, and the horizontal line was truncated at 3000 for graphical reasons (see Table 3 in
Supporting Information for details). Only variable with P< .05 are reported. FECa, fractional excretion of calcium; FECl, fractional excretion
of chloride; FEK, fractional excretion of potassium; FEMg, fractional excretion of magnesium; FENa, fractional excretion of sodium FEP,
fractional excretion of phosphate; HR, hazard ratio; SBP, systolic blood pressure; uCr, urine creatinine; uCr/sCr, urine creatinine to serum
creatinine ratio; UPC, urine protein to creatinine ratio; USG, urine specific gravity; uUA/uCr urine uric acid to urine creatinine ratio; uCr/sCr
urine creatinine to serum creatinine ratio
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our findings. Urinary uric acid has been proposed as a marker of tissue
hypoxia in humans,28,29 and an increase in uUA/uCr occurs in dogs
with volume-responsive AKI and systemic inflammation combined with
alterations in variables of low tissue perfusion.30
Our study documented a significantly lower frequency of death in
dogs with volume-responsive AKI than in those with intrinsic AKI.
According to our diagnostic criteria, dogs with volume-responsive AKI
had an apparently less severe impairment of renal function docu-
mented by a lower AKI grade and sCr upon admission. Although GFR
could not be correctly estimated by sCr during AKI, this hypothesis
might explain the lower case fatality rate noticed in this group. Discrim-
inating intrinsic versus volume-responsive AKI could not have any
apparent therapeutic implication.31 However, the early differentiation
of transient volume-responsive kidney injury from the intrinsic form
could add clinical and prognostic information. In this regard, both the
veterinary clinician and the animal owner could be supported in the
decision-making process and the management of the AKI patient (eg,
predicting the reversibility of kidney failure, or proposing adequate
therapies depending on the expected “renal outcome”). The potential
of urine chemistry to distinguish between these conditions quickly at
the time of AKI diagnosis is, therefore, of value and supports its evalua-
tion in the clinical practice.
The performances of urine chemistry and FE of electrolytes with
respect to AKI diagnosis were variable in our study. In this regard,
FECa, FEK, and uCr/sCr performed excellently (Table 4), showing that
lower FEs and higher uCr/sCr values should be expected in healthy
dogs with normal renal function. On the contrary, and unexpectedly,
FENa was not different between volume-responsive AKI and control
dogs. These latter results are difficult to compare with the available
veterinary literature due to the paucity of data and the lack of inclusion
of healthy control dogs.7,25,32 Moreover there is evidence that AKI in
the course of sepsis and systemic inflammation can trigger severe
sodium retention in humans.16,33 For these reasons, the diagnostic
value of FE of electrolytes other than sodium could be more suitable
for the diagnosis and prediction of AKI in similar settings in dogs.
The case fatality in our study was 41% and is partially in line with
the previous case fatality rates for dogs with AKI.34–36 Although dogs
with volume-responsive and intrinsic AKI showed similar grades of dis-
ease severity at the time of hospital admission, as indicated by similar
Apple Fast scores, dogs with intrinsic AKI had higher IRIS AKI grades
and higher frequencies of death, as previously stated. This result under-
lines the significant impact of intrinsic kidney damage on the overall
patient outcome, independently of the final diagnosis. However,
reversibility of renal dysfunction does not define the absence of mor-
tality risk, as nearly 20% of the enrolled dogs with volume-responsive
AKI died in our study. Limited studies have reported various variables
as potential risk factors for mortality in dogs with AKI, including hyper-
calcemia, hyperphosphatemia, proteinuria, anemia, and different
TABLE 3 Comparison of clinical and clinicopathological variables between surviving (n580) and nonsurviving (n555) dogs with AKI
Variable (n5135) Survivors Nonsurvivors P value
Clinical variables and scores
AKI IRIS grading 2 (1–5) 3 (1–5) .003
UO (mL kg21 h21; over 12 hours) 1.4 (0.2–7.0) 0.7 (0.0–4.7) <.001
APPLE fast score 21.66 5.3 26.566.9 <.001
Serum chemistry (n5 135)
Creatinine (mg/dL) 2.2 (0.6–11.8) 4.4 (0.8–21.4) .002
Phosphate (mg/dL) 6.6 (0.8–30.0) 11.2 (1.8–42.2) <.001
Calcium (mg/dL) 9.96 0.9 9.161.6 .009
Potassium (mmol/L) 4.1 (2.3–8.0) 4.3 (2.7–8.7) .011
Chloride (mmol/L) 107 (605-123) 97 (59–120) .039
Magnesium (mg/dL) 2.52 (1.11-5.60) 3.04 (1.64-6.10) .017
Blood gas analysis (n5135)
pH 7.316 0.08 7.2660.12 .027
HCO–3 (mmol/L) 18.5 (8.5–40.0) 14.7 (6.6–38.1) .005
BE (mmol/L) 25.9 (–17.2–43.0) 29.6 (-28.0–10.7) .003
Anion gap (mmol/L) 18.86 6.9 23.566.9 .002
Ionized calcium (mmol/L) 1.19 (0.64-1.41) 1.09 (0.49-1.38) .003
Urinalysis (n5 125)
UPC (mg/mg) 1.4 (0.1–14.7) 2.7 (0.2–72.0) .001
FENa (%) 0.60 (0.01–50.45) 1.60 (0.03–75.81) .004
FECl (%) 0.57 (0.05–49.24) 2.57 (0.03–83.45) .004
FEK (%) 34.3 (1.6–215.9) 59.9 (5.3–399.7) <.001
FECa (%) 0.6 (0.1–56.1) 4.0 (0.1–70.0) <.001
FEMg (%) 4.8 (0.3–70.6) 12.0 (0.3–131.8) <.001
uGlucose/uCr (mg/mg) 0.13 (0.01–17.37) 0.45 (0.01–58.19) .001
uCr/sCr (mg/mg) 45.5 (1.9–545.9) 17.4 (1.2–377.2) .006
Only statistically significant variables (P< .05) are reported.
Abbreviations: AKI, acute kidney injury; BE, base excess; FECa, fractional excretion of calcium; FECl, fractional excretion of chloride; FEK, fractional
excretion of potassium; FEMg, fractional excretion of magnesium; FENa, fractional excretion of sodium; uCr/sCr, urine creatinine to serum creatinine
ratio; uGlucose/uCr, urine glucose to creatinine ratio; UO, urinary output; UPC, urine protein to creatinine ratio.
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grading systems to reflect AKI severity, while the prognostic role of
azotemia at the time of hospital admission remains
controversial.19,37–40 Recently, increased GFR and UO and decreased
FENa over the course of hospitalization were associated with renal
recovery and predicted survival in a population of 10 dogs with natu-
rally occurring AKI mainly managed using hemodialysis.2 Several clinical
and clinicopathological variables were associated with mortality in our
population of dogs with AKI, including FE of electrolytes; overall, they
were mainly indexes of renal dysfunction and tubular impairment. In
particular, FECa had the best diagnostic and prognostic accuracy
among the FEs evaluated in the study. Moreover, sCr and uCr/sCr
upon admission had a prognostic value in our cohort. These results
might have been influenced by case series composition and AKI etiolo-
gies or mainly by the lack of renal replacement therapy in our setting.
Nevertheless, the prognostic impact of variables that could reflect renal
damage/dysfunction independently of the therapeutic management
available, such as FE of electrolytes, was shown to be more useful in
dogs with AKI, as previously suggested.2
Urinary volume was predictive of death in previous studies in
dogs2,38 and maintains a prognostic role in humans.41 Frequencies of
death were significantly higher in dogs with oligo/anuria (UO <1
mL kg21 h21 for at least 6 hours in the face of euvolemia), and pres-
ence of oligo/anuria was among the variables retained in the univariate
survival analysis. Since most of the dogs showing oligo/anuria at the
time of inclusion in the study had intrinsic AKI, hence the most severe
form of renal disease, this result might be expected in our cohort. How-
ever, frequency of death was significantly higher in dogs with oligo/
anuria than in dogs with intrinsic AKI, confirming the prognostic role of
UO alone when conventional treatment for AKI is performed. These
statements corroborate the clinical usefulness of the IRIS grading sys-
tem for AKI, in which UO is combined with other clinical and laboratory
variables for AKI diagnosis and classification.
According to the survival analysis, BE, iCa, and total bilirubin were
significantly associated with mortality. These data are preliminary and
partially in line with the available literature on AKI in dogs.37 In addi-
tion, the prognostic role of hyperbilirubinemia, metabolic acidosis, and
FIGURE 2 Forest plot reporting results of univariate and multivariate Cox regression analyses for the prediction of mortality in dogs with
AKI. Black rhombus represents HR reported as percentage of risk (HR%). The horizontal black line indicates the 95% confidence interval
values. Asterisk indicates variables retained in the multivariate model. In the univariate model, the horizontal lines indicating the upper limit
of 95% confidence interval for intrinsic AKI (1131) and oligo/anuria (773) were truncated at 500 for graphical reasons (see Table 5 in
supporting information for details). Only variables with P< .05 are reported. ALT, alanine transaminase; BE, base excess; FECa, fractional
excretion of calcium; FECl, fractional excretion of chloride; FEK, fractional excretion of potassium; FEMg, fractional excretion of magnesium;
FENa, fractional excretion of sodium; Hb, hemoglobin concentration; HCT, hematocrit value; HR, hazard ratio; UPC, urine protein to
creatinine ratio. Oliguria/anuria defined as urinary output <1 mL kg–1 h–1 for at least 6 hours
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hypocalcemia has been suggested previously in critically ill dogs in dif-
ferent clinical settings, particularly during sepsis.25,42–44 For these rea-
sons, in our cohort, their prognostic role might have been influenced
by factors other than renal damage, as well as by AKI etiology (eg, lep-
tospirosis, sepsis), and requires further assessment.
There are some limitations to acknowledge when interpreting our
results. No clearance study was performed for our study. Although
clearance techniques using timed urine collection are considered gold
standard to assess the daily urinary solute excretions,32,45,46 a recent
study suggested that FE can be used in clinical practice as a reliable
surrogate for fractional clearance of urinary solutes in dogs.2 Although
unlikely due to the historical, laboratory, and imaging findings of the
dogs in our study, pre-existing renal disease cannot be completely ruled
out. Additionally, specimens and data collected through the overall hos-
pitalization period to assess full renal recovery were not analyzed for
our study nor were novel biomarkers of kidney damage aimed at a bet-
ter characterization of volume-responsive AKI. Finally, previous or
ongoing fluid therapy was not considered as an exclusion criteria for
the study. Although only a minority of dogs was included while on
intravenous fluid therapy (data not shown), the impact of fluid adminis-
tration on FE values should be considered, especially in the comparison
between AKI and control dogs.
In conclusion, our study contributes to the characterization of
AKI in a wide population of critically ill dogs. Volume-responsive
and intrinsic AKI seem to be related to numerous etiologies, mainly
of inflammatory and septic origin. Fractional excretion of electro-
lytes and of uCr/sCr in particular show good performances for the
differentiation between volume-responsive and intrinsic AKI at the
time of diagnosis and could also act as prognostic tools. Their mea-
surement could be suggested in daily practice, as they are feasible
and cost-effective biomarkers of tubular integrity and function. The
clinical application of both sCr and UO criteria to diagnose AKI and
grade the disease in dogs, as performed in our study, could be
strongly recommended in veterinary practice, to raise the suspicion
of the disease in high-risk patients and to obtain prognostic infor-
mation, with significant implications in research and clinical fields.
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TABLE 4 Results of ROC curve analyses evaluating the FE of electrolytes and uCr/sCr for discrimination between study groups
Variable AUC Cut-off Sensitivity (%) Specificity (%) P value
(a) Volume-responsive AKI versus healthy controls
FENa (%) 0.556 <0.64 25 96.3 .336
FECl (%) 0.660 <0.22 55.3 80.0 .004
FEMg (%) 0.685 <3.16 50.0 81.5 <.001a
FECa (%) 0.901 <0.16 91.5 77.5 <.001a,b,c
FEK (%) 0.870 <17.79 70.8 98.8 <.001a,b,c
uCr/sCr (mg/mg) 0.883 >163 83.3 81.5 <.001a,b,c
(b) Intrinsic versus volume-responsive AKI
FENa (%) 0.856 >0.90 83.3 75.8 <.001
FECl (%) 0.872 >0.53 78.7 83.9 <.001
FEMg (%) 0.879 >4.93 82.6 83.6 <.001
FECa (%) 0.885 >0.55 76.6 90.3 <.001
FEK (%) 0.868 >33.9 77.1 85.5 <.001
uCr/sCr (mg/mg) 0.883 <33.6 87.5 90.0 <.001
(c) Survivors versus nonsurvivors
FENa (%) 0.654 >4.38 41.7 93.4 .004
FECl (%) 0.657 >7.49 38.3 94.7 .005
FEMg (%) 0.697 >11.64 51.1 85.3 <.001
FECa (%) 0.701 >3.41 55.3 81.6 <.001
FEK (%) 0.692 >130 35.4 96.1 <.001
uCr/sCr (mg/mg) 0.646 7.36 41.7 93.5 .008
Cut-off values with the maximal sum of sensitivity and specificity are provided to identify controls (a), intrinsic AKI (b) and non-survivors (c).
Abbreviations: AUC, area under the curve; FECa, fractional excretion of calcium; FECl, fractional excretion of chloride; FEK, fractional excretion of
potassium; FEMg, fractional excretion of magnesium; FENa, fractional excretion of sodium; ROC, receiver operator characteristic; uCr/sCr, urine creati-
nine to serum creatinine ratio. P value refers to the ROC curve analysis for single variables.
aSignificantly different from FENa in the ROC curve comparison.
bSignificantly different from FECl in the ROC curve comparison.
cSignificantly different from FEMg in the ROC curve comparison.
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